Financial Data and Key Metrics Changes - In 2025, the company achieved a record HIFU revenue of EUR 33.1 million, a 39% increase from EUR 23.8 million in 2024 [16] - Total revenue for 2025 was EUR 62.4 million, a 3% decrease from EUR 64.1 million in 2024, primarily due to a 27% decline in non-core distribution and ESWL businesses [17] - Q4 2025 HIFU revenue reached EUR 11.7 million, a 34% increase from EUR 8.8 million in Q4 2024 [18] - Gross margin for Q4 was EUR 8.1 million, with a gross margin percentage of 42.6%, down from 44.8% in Q4 2024 [19] Business Line Data and Key Metrics Changes - The HIFU segment saw a 59% increase in the number of Focal One system units sold and a 19% increase in treatment-driven revenue [17] - The company recorded 15 Focal One placements in Q4, including 14 cash sales, marking the strongest quarter for placements and cash sales [5] - Focal One procedure volumes in the U.S. grew 28% year-over-year in Q4 2025 [10] Market Data and Key Metrics Changes - The U.S. market was a significant driver, with 10 cash sales in Q4, the highest quarterly total on record [5] - Internationally, the company achieved 4 cash sales outside the U.S., including its first placements in India and Argentina [9] Company Strategy and Development Direction - The company aims to expand its penetration across leading academic centers and community hospitals, focusing on the early adoption lifecycle of the Focal One technology [24] - Plans include expanding clinical indications beyond prostate cancer, with ongoing clinical trials for BPH and endometriosis [12][13] - The company is advancing AI-driven treatment planning and next-generation imaging capabilities to maintain its leadership in robotic focal therapy [25] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the 2026 outlook, expecting core HIFU revenue to be between $50 million and $54 million, representing 34%-45% growth over 2025 [22] - The reimbursement landscape is favorable, with a 4.6% increase in the national facility payment average for 2026 [11] Other Important Information - The company received FDA clearance for the latest evolution of Focal One robotic HIFU, introducing advanced ultrasound imaging [10] - Inventory decreased to EUR 10.9 million at quarter end, reflecting disciplined inventory management [21] Q&A Session Summary Question: Can you provide more details on the growth in procedures versus capital sales? - Management noted strong pipelines in both U.S. and international markets, with procedure growth increasing 28% year-over-year in Q4 [28][30] Question: What is the expected revenue split between the first and second half of 2026? - The company anticipates Q4 to be the highest growth quarter, with less than 50% of business occurring in the first half of the year [36] Question: How is the non-core business expected to decline? - The ESWL business constitutes 20%-25% of the non-core revenue, and the company is evaluating distribution agreements for their materiality and gross margin contribution [38] Question: What impact do tariffs have on margins? - The company has budgeted about $2.5 million in tariffs for 2026, impacting U.S. revenue from products shipped from France [42] Question: How has the cash sales situation evolved? - Management indicated that concerns regarding cash sales have mitigated, with a focus on leading with cash sales moving forward [45]

Financial Data and Key Metrics Changes - Revenue for Q4 FY 2026 was $106.2 million, an increase of $11.7 million or 12.4% year-over-year, reflecting a healthy demand environment [17] - Non-GAAP gross margin reached a record of 74.7%, an expansion of 320 basis points year-over-year [19] - GAAP net income was $5.1 million compared to a net loss of $0.2 million in the same period last year [20] - For FY 2026, revenue was $400 million, up 14.1% year-over-year, with GAAP operating income reaching $13.3 million, a significant turnaround from a $5.1 million GAAP operating loss last year [23] Business Line Data and Key Metrics Changes - Software revenue was $45.9 million, an increase of $8.5 million or 22.6% year-over-year, while software services revenue grew by $3.4 million to $49.3 million [17][18] - Recurrent revenue increased by 5.6% to $50 million, representing 47.1% of total revenue [18] Market Data and Key Metrics Changes - The company added 61 new customers in FY 2026, reflecting strong demand across various segments, including military intelligence and law enforcement [9] - The North American market is a key focus, with new leadership and partnerships aimed at expanding presence [10] Company Strategy and Development Direction - The company aims for revenue guidance of $448 million for FY 2027, representing approximately 12% year-over-year growth [7][26] - The strategy includes expanding the install base, acquiring new customers, and scaling operations in the U.S. market [10][12] Management's Comments on Operating Environment and Future Outlook - Management noted that the demand for mission-critical intelligence technology is driven by increasingly complex threats and the need for faster decision-making [7][12] - The company is well-positioned to address the growing reliance on AI in operational environments, which is seen as a structural tailwind for the business [14][16] Other Important Information - The company ended FY 2026 with $116.9 million in cash and no debt, providing significant strategic flexibility [24] - An additional $20 million was approved for the share repurchase program, reflecting the board's commitment to long-term shareholder value creation [25] Q&A Session Summary Question: Strong bookings growth based on RPO - Management highlighted consistent demand drivers across geographies and customer segments, with several multimillion-dollar deals contributing to strong RPO [34][35] Question: U.S. business mix and future expectations - Management indicated that about 25% of the incremental revenue growth to reach $500 million by FY 2028 is expected to come from the U.S. market [39][40] Question: Cash flow and collection delays - Management explained that cash flow from operations was impacted by delays in collections, but overall cash generation remains strong [41][54] Question: Adjusted EBITDA and sources of leverage - Management noted that gross margin improvements and controlled operating expenses are key sources of leverage for future growth [43][44] Question: Impact of geopolitical events on pipeline - Management acknowledged that security concerns typically translate into increased demand for their solutions, particularly in military intelligence [63][64]

Financial Data and Key Metrics Changes - Revenue for Q4 2025 was $30.1 million, representing a 629% year-over-year increase and nearly 200% sequential growth from Q3 2025, reflecting strong demand across the Ondas Autonomous Systems segment [30] - Full-year revenue for 2025 reached $50.7 million, a 605% increase compared to $7.2 million in 2024, validating the strength of the core business and the impact of the strategic growth program [34] - Gross profit for Q4 2025 was $12.7 million, resulting in a gross margin of 42%, significantly improved from 21% in the prior year [31] - The company ended the year with a pro forma cash balance of over $1.5 billion, providing significant financial flexibility for executing growth strategies [10][36] Business Line Data and Key Metrics Changes - The Ondas Autonomous Systems segment saw strong organic revenue growth of 63% year-over-year, driven by continued deliveries of Iron Drone and Optimus systems [30] - The company announced five strategic acquisitions in Q1 2026, which are expected to enhance capabilities across multiple domains and contribute to revenue growth [10][48] Market Data and Key Metrics Changes - The joint venture ONBERG with Heidelberger is positioned to meet rising defense spending in Europe, particularly in Germany and Ukraine, where demand for autonomous systems is immediate [12] - The acquisition of World View adds a unique capability in stratospheric sensing, expanding Ondas' market reach into critical defense and commercial ISR applications [13][20] Company Strategy and Development Direction - Ondas is focused on building a scaled operating platform to support global deployment and long-term growth, with a strategy that emphasizes integration and expansion across multiple domains [4][10] - The company aims to leverage its acquisitions to create a multi-domain ISR platform, integrating sensing, data, and decision-making into a unified operational system [16][27] - The strategic growth program is expected to drive significant revenue growth and enhance the overall quality of earnings over time [59] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the company's ability to scale and achieve significant revenue growth in 2026, raising the revenue outlook to at least $375 million [9][67] - The company anticipates increased operating expenses in the first half of 2026 due to investments in personnel and infrastructure, but expects to see meaningful improvement in cash efficiency as revenue scales [39][68] Other Important Information - The company has a robust M&A pipeline with over $500 million of potential revenue across active opportunities, focusing on quality and strategic alignment in acquisitions [66] - Ondas Networks has been formally adopted by the Association of American Railroads as a foundational technology provider for next-generation rail communications, indicating strong market validation [44] Q&A Session Summary Question: What is the outlook for revenue growth in 2026? - The company has increased its 2026 revenue target to at least $375 million, reflecting strong growth across both core business and contributions from recent acquisitions [67] Question: How will the recent acquisitions impact financial performance? - The acquisitions are expected to generate approximately $230 million of revenue in 2026, significantly enhancing the financial model and supporting operating leverage [58]

Financial Data and Key Metrics Changes - In 2025, total revenue reached RMB 2.37 billion, representing a 135% year-over-year growth [4][15] - Product sales reached RMB 1.44 billion, up 43% over the previous year [4][15] - Net profit reached RMB 644 million, marking the company's first year with a profit [4][17] - Cash position at the end of 2025 was RMB 2.8 billion, supporting continued R&D investment [5][17] - R&D expenses were RMB 950 million, reflecting a 16.9% year-over-year growth [17][61] Business Line Data and Key Metrics Changes - Orelabrutinib was approved for first-line treatment of CLL/SLL and included in NRDL, expanding commercial space [5][11] - Tafasitamab was approved for DLBCL in mainland China, enhancing the company's oncology portfolio [5][11] - Zurletrectinib was approved for marketing in China, marking the company's first approved therapy in solid tumors [11][40] Market Data and Key Metrics Changes - The company entered into strategic collaborations with Zenas BioPharma and Freelium, unlocking significant value with total BD deal value exceeding $2.5 billion [5][19] - Globalization is becoming a key growth pillar, with major out-license transactions covering four assets [19] Company Strategy and Development Direction - The company aims to become a global pharmaceutical leader focused on innovative therapies for oncology and autoimmune diseases [4] - A diversified product portfolio is being developed, with multiple commercial and late-stage assets driving future expansion [15][18] - The company is investing in next-generation platforms such as ADC and molecular glue technologies [17][61] Management Comments on Operating Environment and Future Outlook - Management expressed confidence in achieving over 35% growth in drug sales for 2026, driven by Orelabrutinib, Tafasitamab, and Zurletrectinib [18][54] - The company achieved profitability ahead of schedule, with expectations for sustainable breakeven in 2026 and 2027 [54][56] Other Important Information - The company has over 10 phase III registrational studies ongoing globally, with multiple major products expected to receive regulatory approvals in the next 2-3 years [14][20] - The pipeline includes innovative therapies for autoimmune diseases, with significant market potential exceeding $150 billion [36][29] Q&A Session Summary Question: What is the sales potential for Orelabrutinib in 2026? - Management expects continued growth over 30% for Orelabrutinib, driven by deeper penetration in CLL and MCL, and broader hospital coverage [52][53] Question: What is the development plan for ICP-488 overseas? - The company plans to expand indications after the phase III readout and is open to partnerships for global development [57][59] Question: What is the forecast for R&D expenses in 2026? - R&D expenses are expected to grow around 20% in 2026, focusing on late-stage clinical studies and innovation platforms [61][62] Question: How will the company position its TYK2 inhibitors amid competition? - The company believes its TYK2 inhibitors have broader potential beyond psoriasis, targeting multiple autoimmune diseases [72][73] Question: What are the inclusion criteria for the Orelabrutinib plus Mesutoclax data? - The combination therapy targets unfit older patients, achieving a 65% MRD-negative rate, demonstrating good results in this population [79]

Financial Data and Key Metrics Changes - The company achieved a record high quarterly revenue of RMB 2.76 billion, representing a year-over-year growth of 24% [7][17] - Revenue from Public Cloud Services increased by 35% to RMB 1.9 billion, up from RMB 1.41 billion in the same quarter last year [19] - Adjusted gross margin rose to 70% from 60% in the previous quarter, driven by a shift in revenue structure [18][21] - Adjusted operating profit reached RMB 55 million, marking a 124% increase from RMB 24 million in the same period last year [22] Business Line Data and Key Metrics Changes - Revenue from the AI business reached RMB 926 million, representing a 95% year-over-year growth and contributing 49% of Public Cloud Services [7][17] - Enterprise Cloud revenue was RMB 859 million, showing an 18% quarter-over-quarter increase [11][19] - Revenue from the Xiaomi and Kingsoft ecosystem reached RMB 804 million, a 63% year-over-year increase, accounting for 29% of total revenue [8] Market Data and Key Metrics Changes - The company noted strong demand from various sectors including automotive manufacturing, autonomous driving, and fintech, diversifying its customer base [10] - The top five non-ecosystem customers saw a revenue growth of 44% year-over-year, indicating strong external demand [46] Company Strategy and Development Direction - The company is committed to a high-quality and sustainable development strategy, focusing on AI-driven opportunities and enhancing its technological capabilities [6][16] - The strategy includes a "1+N" approach, where the Xiaomi MiMo model serves as a key component of the inference strategy within the ecosystem [31] - The company aims to build a next-generation computing services system for large language model training and inference, transitioning to an AI-first cloud architecture [14][15] Management Comments on Operating Environment and Future Outlook - Management highlighted the unprecedented demand for intelligent computing driven by the AI industry, emphasizing the importance of cloud computing in this evolution [6][10] - The company plans to further invest in infrastructure and enhance service stability to capitalize on the growing demand for AI services [25] - Management expressed confidence in the ability to monetize intelligent cloud opportunities and improve profitability [22][25] Other Important Information - The company achieved operating level profitability for two consecutive quarters, indicating improved self-funding capabilities [9] - Cash and cash equivalents reached RMB 6.08 billion, strengthening the company's investment capacity in AI [18] Q&A Session Summary Question: Positioning within Xiaomi's AI strategy and future plans - The company will focus on supporting Xiaomi's AI strategy without developing its own large language models, adhering to a collaborative ecosystem approach [30][31] Question: Current pricing trends in the cloud service industry - The company plans to maintain pricing for existing contracts but may increase prices for new customers based on demand and cost increases [32] Question: Shift towards traditional server rental and subscription models - The company recognizes the trend but emphasizes its existing model as a service strategy, which is already a significant growth area [38] Question: Impact of ByteDance's Volcano Engine pricing strategy - Management noted that while there is high demand and supply chain price increases, lowering prices may not be feasible in the current market [39][40] Question: Financial outlook and capital expenditure plans - The company expects capital expenditures to exceed RMB 10 billion in 2026, with a significant portion covered by customer prepayments [44][45] - Growth in revenue and EBITDA is anticipated to accelerate in 2026, driven by strong demand from both ecosystem and non-ecosystem customers [46]

Financial Data and Key Metrics Changes - The company achieved a record high quarterly revenue of RMB 2.76 billion, representing a year-over-year growth of 24% [7][17] - Revenue from public cloud services increased by 35% to RMB 1.9 billion [7][19] - The gross billing of AI business reached RMB 926 million, representing a 95% year-over-year growth [7][17] - Adjusted gross margin increased to 70% from 60% in the previous quarter [18][22] - Adjusted operating profit reached RMB 55 million, with a margin of 2% [23][18] Business Line Data and Key Metrics Changes - Revenue from enterprise cloud services reached RMB 859 million, a quarter-over-quarter increase of 18% [11][19] - Revenue from the Xiaomi and Kingsoft ecosystem reached RMB 804 million, a 63% year-over-year increase [8] - Revenue from top 5 non-ecosystem customers grew by 44% year-over-year [8][49] Market Data and Key Metrics Changes - The company noted strong demand from various sectors including automotive manufacturing, autonomous driving, and Fintech [10] - The AI business is expected to represent a trillion-dollar market opportunity, driving technological advancements across industries [12] Company Strategy and Development Direction - The company is committed to a high-quality and sustainable development strategy, focusing on AI-driven opportunities [6][16] - The strategy includes a "1+N" approach within the Xiaomi and Kingsoft ecosystem, emphasizing collaboration and monetization of model as a service capabilities [32][33] - The company aims to build a next-generation computing services system for LLM training and inference, transitioning to an AI-native cloud architecture [14][15] Management Comments on Operating Environment and Future Outlook - Management highlighted the unprecedented demand for intelligent computing driven by the AI industry [6] - The company plans to further invest in infrastructure and enhance service stability to meet rising demand [26] - The outlook for 2026 includes expectations for accelerated growth and improved EBITDA margins [48] Other Important Information - The company achieved operating level profitability for two consecutive quarters, indicating improved self-funding capability [9] - Cash and cash equivalents reached RMB 6.08 billion, strengthening the company's investment capacity [18] Q&A Session Summary Question: Positioning within Xiaomi's AI strategy and pricing adjustments - Management stated that Kingsoft will focus on supporting Xiaomi's AI strategy without developing its own large language models, while pricing adjustments will depend on existing contracts and demand [31][34] Question: Shift towards model as a service and impact of Volcano Engine's pricing - Management acknowledged the trend towards model as a service, emphasizing their existing StarFlow platform, and noted that price adjustments in the market are influenced by supply chain dynamics [38][42] Question: Financial outlook and capital expenditure plans - Management expects total CapEx for 2026 to exceed RMB 10 billion, with a significant portion covered by customer prepayments, and anticipates strong growth in revenue and EBITDA [47][48]

Financial Data and Key Metrics Changes - The company achieved a record high quarterly revenue of RMB 2.76 billion, representing a year-over-year growth of 24% [6][17] - Revenue from public cloud services increased by 35% to RMB 1.9 billion [6][19] - The gross billing of AI business reached RMB 926 million, representing a 95% year-over-year growth [6][17] - Adjusted gross margin increased to 70% from 60% in the previous quarter [17][21] - Adjusted operating profit reached RMB 55 million, marking a 124% increase from the previous year [23] Business Line Data and Key Metrics Changes - Revenue from enterprise cloud services reached RMB 859 million, a quarter-over-quarter increase of 18% [11][19] - Revenue from the Xiaomi and Kingsoft ecosystem reached RMB 804 million, a 63% year-over-year increase [8] - Revenue from top 5 non-ecosystem customers grew by 44% year-over-year [8][49] Market Data and Key Metrics Changes - The company serves a diversified customer base, including automotive manufacturing, autonomous driving, and Fintech sectors [10] - The demand for AI services is driving significant growth, with external customers accounting for around 70% of total revenue [8] Company Strategy and Development Direction - The company is committed to a high-quality and sustainable development strategy, focusing on AI-driven opportunities [5][16] - The strategy includes a "1+N" model, where the Xiaomi MiMo model serves as a key component of the inference strategy [32][33] - The company aims to enhance its capabilities in AI and cloud computing, positioning itself to capture industrial transformation opportunities [12][14] Management's Comments on Operating Environment and Future Outlook - Management highlighted the unprecedented demand for intelligent computing driven by the AI era [5][6] - The company plans to invest further in infrastructure to support AI business growth and improve operating efficiency [26][48] - The outlook for 2026 includes expectations for accelerated growth and improved EBITDA margins [48] Other Important Information - The company achieved operating level profitability for two consecutive quarters, indicating improved self-funding capability [9] - Total cash and cash equivalents reached RMB 6.08 billion, strengthening the company's investment capacity [18] Q&A Session Summary Question: Role within Xiaomi's AI strategy and future plans - The company will focus on supporting Xiaomi's AI strategy without developing its own large language models, adhering to a collaborative ecosystem approach [32][33] Question: Current pricing trends in the cloud service industry - The company plans to maintain pricing for existing contracts but may increase prices for new customers based on demand and cost increases [34] Question: Shift towards a model as a service strategy - The company is already implementing a model as a service strategy through its StarFlow platform, which is experiencing rapid growth [40] Question: Impact of Volcano Engine's pricing strategy - Management noted that while there is significant demand growth, lowering prices in the current market dynamics may not be feasible [41]

Financial Data and Key Metrics Changes - Revenue reached RMB 21.8 billion, a 16.7% increase from 2024, with a sequential growth of about 18% in the second half compared to the first half [25][26] - Adjusted net profit increased by 22% year-over-year to RMB 6.6 billion, with a margin expansion of 130 basis points to 30.2% [32][34] - Adjusted EBITDA rose by 22.8% to RMB 9.8 billion, with an adjusted EBITDA margin of 45.1%, one of the highest in the global CDMO industry [32][34] Business Line Data and Key Metrics Changes - Research and discovery services saw a doubling of upfront payments to $115 million, with potential milestone income streams exceeding $4 billion [27] - Development revenue grew by approximately 32% year-over-year, driven by 209 new projects, with 186 in the pre-IND space [28] - Manufacturing revenue from late-phase and commercial projects grew over 26% year-over-year, now representing over 43% of the total portfolio [29] Market Data and Key Metrics Changes - The U.S. accounted for 58% of revenue, growing over 18%, while Europe contributed 23% with nearly 17% growth [16] - Japan and Korea experienced significant growth of almost 70%, now representing 6.5% of total revenue [16][17] - China saw a slight decline in revenue, but adjusting for out-licensing deals shows nearly flat year-over-year growth [17][18] Company Strategy and Development Direction - The company emphasizes a unique CRDMO business model, focusing on bi-specifics, ADCs, and traditional mAbs to drive sustainable high growth [3][4] - The strategy includes expanding capabilities in complex modalities, which are expected to enhance market share due to their challenging nature [20][21] - Continuous investment in technology and capacity expansion in key markets like the U.S. and Singapore is planned to support future growth [59][60] Management's Comments on Operating Environment and Future Outlook - Management acknowledges geopolitical uncertainties but remains optimistic about sustained growth driven by a strong project funnel and client trust [8][14] - The company expects to continue delivering high growth, with a focus on maintaining a sticky project funnel despite external challenges [14][19] - Future revenue growth is anticipated from the successful execution of projects and the introduction of new technologies [58][64] Other Important Information - The company reported a significant increase in gross profit, reaching over RMB 10 billion, with a 31% increase in gross profit margin [30][37] - The company has a strong balance sheet with RMB 15.7 billion in cash, supporting accelerated global growth [41][43] - The company is committed to continuous improvement through the WuXi Business System, achieving a 150 basis points improvement in margin [70] Q&A Session Summary Question: What are the key drivers of revenue growth? - Revenue growth was driven by R&D services, particularly in bispecifics and ADCs, with a strong pipeline of new deals expected to continue into 2026 [27][28] Question: How does the company plan to manage geopolitical risks? - The company acknowledges the geopolitical noise but emphasizes the stickiness of its project funnel and strong client relationships as mitigative factors [8][14] Question: What is the outlook for the manufacturing segment? - The manufacturing segment is expected to grow significantly, with a focus on late-phase projects and commercial manufacturing, which have shown strong revenue growth [29][30]

Financial Data and Key Metrics Changes - For fiscal year 2025, revenue reached RMB 3.98 billion, up 43.5%, with net profit attributable to ordinary shareholders at RMB 570 million, a year-on-year growth of 64.8% [4] - Quarterly revenue in Q4 more than doubled year-on-year to RMB 1.41 billion, reflecting a growth of 105.5% [20] - Operating costs for Q4 reached RMB 680 million, a 109.2% increase year-on-year, driven by referral and service fees [21] Business Line Data and Key Metrics Changes - The insurtech segment saw revenue surge by 61.3% with an operating margin of approximately 18% [4] - Insurance-related income in Q4 surged 125% year-over-year to RMB 1.31 billion, while operating profits grew 42% year-over-year to RMB 160 million [9] - Medical consulting services generated RMB 260 million, while digital clinical trial sourcing income was RMB 118 million [20] Market Data and Key Metrics Changes - The platform has responded to 3.68 million patients since its launch, with over 4,000 patients enrolled in digital clinical trials this year [5] - The E-Find platform partnered with 224 pharmaceutical companies and enrolled a record 14,055 patients [16] Company Strategy and Development Direction - The company is accelerating its shift to become an AI-native company, aiming to embed AI as a structural competitive advantage [6][8] - The goal for 2026 is to sustain momentum with moderately higher investment in marketing and AI, targeting double-digit growth in both revenue and profit [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in the execution of the AI plus insurance strategy, highlighting robust financial performance and core fundamentals [3] - The company aims to visually reconstruct its entire value chain with AI, indicating a strong commitment to innovation and efficiency [8] Other Important Information - The board approved a cash dividend of $0.03 per ADS, totaling $10.8 million, to be paid in late April to early May [5] - The company maintained a strong cash position of about RMB 3.25 billion as of the end of 2025, supporting future growth [22] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.

Financial Data and Key Metrics Changes - For fiscal year 2025, revenue reached CNY 3.98 billion, up 43.5%, with net profit attributable to ordinary shareholders at CNY 570 million, a year-on-year growth of 64.8% [4][21] - The company has achieved GAAP profitability for 16 consecutive quarters, indicating strong financial health [4] - Operating costs for the fourth quarter reached CNY 680 million, a 109.2% year-over-year increase, driven by rising referral and service fees [19] Business Line Data and Key Metrics Changes - The insurtech segment saw revenue surge by 61.3% with an operating margin of approximately 18% [4] - Insurance-related income in the fourth quarter increased 125% year-over-year to CNY 1.31 billion, while operating profits grew 42% year-over-year to CNY 160 million [9] - Medical consulting services generated CNY 260 million, and digital clinical trial sourcing income was CNY 118 million, accounting for about 10.1% of total revenue [18] Market Data and Key Metrics Changes - Approximately 490 million people have cumulatively donated CNY 72.3 billion to 3.68 million patients through the Waterdrop medical crowdfunding platform [13] - The E-Find platform partnered with 224 pharmaceutical companies and enrolled a record 14,055 patients, achieving significant growth [14][15] Company Strategy and Development Direction - The company is focusing on becoming an AI-native organization, embedding AI as a structural competitive advantage across its value chain [7][8] - Aiming for double-digit growth in both revenue and profit, the company plans to moderately increase investment in marketing and AI [8] Management's Comments on Operating Environment and Future Outlook - Management expressed confidence in sustaining growth momentum, highlighting the successful execution of the AI plus insurance strategy [3][4] - The company is committed to enhancing user privacy and risk control through advanced technology, ensuring data security and authenticity [13][14] Other Important Information - The board approved a cash dividend of $0.03 per ADS, totaling $10.8 million, to be paid in late April to early May [4][5] - The company has filed 72 LLM-related patent applications, indicating a strong focus on innovation and technology [5] Q&A Session Summary - No specific questions and answers were provided in the content, thus this section is not applicable.